Hot Pursuit     11-Aug-21
Sequent Scientific Ltd Slips 13.82%, S&P BSE Healthcare index Shed 1.19%
Sequent Scientific Ltd has lost 10.85% over last one month compared to 0.56% gain in S&P BSE Healthcare index and 4.31% rise in the SENSEX

Sequent Scientific Ltd fell 13.82% today to trade at Rs 241.55. The S&P BSE Healthcare index is down 1.19% to quote at 26051.58. The index is up 0.56 % over last one month. Among the other constituents of the index, Lupin Ltd decreased 5.98% and Fermenta Biotech Ltd lost 3.57% on the day. The S&P BSE Healthcare index went up 34.43 % over last one year compared to the 42.24% surge in benchmark SENSEX.

Sequent Scientific Ltd has lost 10.85% over last one month compared to 0.56% gain in S&P BSE Healthcare index and 4.31% rise in the SENSEX. On the BSE, 1.63 lakh shares were traded in the counter so far compared with average daily volumes of 1.48 lakh shares in the past one month. The stock hit a record high of Rs 336.4 on 29 Jun 2021. The stock hit a 52-week low of Rs 120.1 on 19 Aug 2020.

Previous News
  Lupin fixes record date for dividend
 ( Market Beat - Reports 04-Jul-24   15:27 )
  Market hits fresh life highs; Nifty ends above 24,000 level
 ( Market Commentary - The Week That Was 28-Jun-24   16:33 )
  Lupin to pay fine of Euro 40 million to European Commission
 ( Corporate News - 28-Jun-24   09:08 )
  Lupin gains on receiving EIR from USFDA for New Jersey facility
 ( Hot Pursuit - 24-Jun-24   10:32 )
  Lupin allots 43,475 equity shares under ESOP
 ( Corporate News - 21-Jun-24   12:12 )
  Lupin Ltd slips for fifth straight session
 ( Hot Pursuit - 18-Jun-24   13:35 )
  Lupin appoints Abdelaziz Toumi as CEO of API CDMO arm
 ( Hot Pursuit - 17-Jun-24   12:28 )
  Lupin appoints Abdelaziz Toumi as CEO of Lupin Manufacturing Solutions
 ( Corporate News - 17-Jun-24   12:05 )
  Lupin Nagpur unit clears USFDA inspection
 ( Hot Pursuit - 14-Jun-24   11:24 )
  Lupin's Nagpur facility successfully clears USFDA audit
 ( Corporate News - 14-Jun-24   10:25 )
  Lupin to transfer its trade generics biz in India to Lupin Life Sciences
 ( Corporate News - 08-Jun-24   14:09 )
Other Stories
  Reliance Industries Ltd up for third straight session
  08-Jul-24   13:06
  Oil & Natural Gas Corpn Ltd rises for third consecutive session
  08-Jul-24   13:05
  Zydus Lifesciences Ltd spurts 0.43%, up for five straight sessions
  08-Jul-24   13:01
  Dr Reddys Laboratories Ltd gains for fifth session
  08-Jul-24   13:01
  HPL Electric soars after inking MoU with China-based Guangxi Ramway Tech
  08-Jul-24   12:40
  J&K Bank records 11% YoY growth in gross advances in Q1 FY25
  08-Jul-24   12:30
  Krebs Biochemicals & Industries Ltd leads gainers in 'B' group
  08-Jul-24   12:16
  Nykaa expects revenue growth around 22 to 23% YoY in Q1 FY25
  08-Jul-24   12:05
  Ajmera Realty spurts as sales value climbs 36% YoY in Q1
  08-Jul-24   12:02
  Kiri Industries Ltd leads gainers in 'A' group
  08-Jul-24   12:01
Back Top